Cinemark Holdings

CNK · NYSE

$40.15+$1.15 (+2.95%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $39.00

CNK analyst rating

HoldConsensus of 10 analysts over the last 12 months. 40% rate it a buy.

Strong buy0
Buy4
Hold6
Underperform0
Sell0

12-month price target · 14 analysts

Average $41.14 (+2.5% upside)

Low: $34.34
Now: $40.15
High: $47.25

Upgrades and downgrades

The latest rating actions, newest first

CNK analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Morgan Stanley	Sep 24, 2026	Maintains	Equal-Weight	$42.00 → $40.00	0%
Macquarie	Sep 2, 2026	Maintains	Outperform	$42.00 → $44.00	40%
JP Morgan	Aug 14, 2026	Downgrade	Overweight → Neutral	$40.00 → $39.00	69%
JP Morgan	Jul 31, 2026	Maintains	Overweight	$35.00 → $40.00	69%
B. Riley Securities	Jul 31, 2026	Maintains	Neutral	$35.00 → $37.00	59%
Wells Fargo	Jul 31, 2026	Maintains	Equal-Weight	$31.00 → $34.00	67%
Benchmark	Jul 31, 2026	Maintains	Buy	$37.00 → $40.00	54%
Wedbush	Jul 31, 2026	Maintains	Outperform	$40.00 → $43.00	56%
Macquarie	Jul 30, 2026	Maintains	Outperform	$38.00 → $42.00	40%
Wedbush	Jul 29, 2026	Maintains	Outperform	$37.00 → $40.00	56%

The case for and against

Updated Oct 15, 2026

Bull case

Cinemark Holdings is well positioned by firmer theatrical windows, a stronger 2026 slate, and studio support that should lift attendance and improve the durability of box office revenue. Its operating momentum is reinforced by record concessions per cap of $8.58, domestic admission revenue growth of 22.3%, and a 2.6x leverage ratio that supports both investment and shareholder returns. Ongoing upgrades in recliners, expanded concessions, PLF formats, and new screens, alongside continued market share gains versus pre-pandemic trends, strengthen the case for sustained revenue and EBITDA growth.

Bear case

Cinemark Holdings is facing a cautious fundamental backdrop despite first quarter revenue of $643.1 million and EBITDA of $88.5 million, because the business remains highly dependent on attendance trends and film slate mix to sustain pricing power and cash generation. While stronger concessions spending and margins helped offset some weakness, overall attendance was still softer than expected, particularly in Latin America, highlighting uneven demand across its geographic footprint. With EPS at -$0.06, the company’s profitability remains fragile, and its reliance on U.S.-driven revenue leaves it exposed if box office momentum or consumer spending on concessions slows.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.